Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. | Elife | 2022 | 35587364 | PubTator, text mining | PubMed |
| Spatially resolved in silico modeling of NKG2D signaling kinetics suggests a key role of NKG2D and Vav1 Co-clustering in generating natural killer cell activation. | PLoS Comput Biol | 2022 | 35584138 | PubTator, text mining | PubMed |
| Tumor-derived exosomes: immune properties and clinical application in lung cancer. | Cancer Drug Resist | 2022 | 35582534 | PubTator, text mining | PubMed |
| Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells. | J Immunother Cancer | 2022 | 35580928 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective. | J Oncol | 2022 | 35578600 | PubTator, text mining | PubMed |
| A Novel Risk Model Based on Autophagy-Related LncRNAs Predicts Prognosis and Indicates Immune Infiltration Landscape of Patients With Cutaneous Melanoma. | Front Genet | 2022 | 35571053 | PubTator, text mining | PubMed |
| CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma. | Front Genet | 2022 | 35571047 | PubTator, text mining | PubMed |
| Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer. | Molecules | 2022 | 35566016 | PubTator, text mining | PubMed |
| Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression. | Cancers (Basel) | 2022 | 35565467 | PubTator, text mining | PubMed |
| Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. | Cancers (Basel) | 2022 | 35565420 | PubTator, text mining | PubMed |
| Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release. | Front Immunol | 2022 | 35558071 | PubTator, text mining | PubMed |
| Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. | Biomark Res | 2022 | 35550636 | PubTator, text mining | PubMed |
| The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas. | Front Mol Biosci | 2022 | 35547391 | PubTator, text mining | PubMed |
| 3D modelling of γδ T-cell immunotherapy. | Clin Transl Med | 2022 | 35538922 | PubTator, text mining | PubMed |
| Genetic basis of cardiovascular aging is at the core of human longevity. | J Cardiovasc Aging | 2022 | 35531366 | PubTator, text mining | PubMed |
| Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2022 | 35528973 | PubTator, text mining | PubMed |
| HLA class I chain-related MICA and MICB genes polymorphism in healthy individuals from the Bulgarian population. | Hum Immunol | 2022 | 35525711 | PubTator, text mining | PubMed |
| Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations. | Onco Targets Ther | 2022 | 35509452 | PubTator, text mining | PubMed |
| Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates. | Sci Rep | 2022 | 35504942 | PubTator, text mining | PubMed |
| Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian. | Cancer Cell Int | 2022 | 35488336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=38